| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/22/2013 | CN101528713B Pyridazine derivatives used as 11 beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 05/22/2013 | CN101010068B Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof |
| 05/21/2013 | US8445434 IGF-1 fusion polypeptides and therapeutic uses thereof |
| 05/21/2013 | US8445432 Neurturin molecules |
| 05/21/2013 | US8445425 Urocortin-III and uses thereof |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8445013 Stable pharmaceutical composition and methods of using same |
| 05/21/2013 | CA2548918C Alpha-amino acid derivatives and use thereof as medicines |
| 05/21/2013 | CA2547934C Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2396688C Glycosidase inhibitors and methods of synthesizing same |
| 05/16/2013 | WO2013070961A1 Modulators of atp-binding cassette transporters |
| 05/16/2013 | WO2013069934A1 Composition for treating and preventing obesity, containing wheatgrass extract as active ingredient |
| 05/16/2013 | WO2013068935A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists |
| 05/16/2013 | WO2013068774A1 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them |
| 05/16/2013 | WO2013068715A1 Morus extracts rich in n-acids of imino sugars and or pipecolic acids |
| 05/16/2013 | WO2013068439A1 4-amino-5-oxo-7,8-dihydropyrimido[5, 4 -f] [1, 4] oxazepine compounds as dgat1 inhibitors |
| 05/16/2013 | WO2013068328A1 Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors |
| 05/16/2013 | WO2013068306A1 [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | WO2013067579A1 Adiposity-modulating molecules and uses therefor |
| 05/16/2013 | WO2013067578A1 Modulators of c3a receptors |
| 05/16/2013 | WO2012165888A3 Composition for treating obesity and diabetes and for increasing muscle mass and improving capacity for exercise, comprising extracts of piper retrofractum vahl. fruits as active ingredients |
| 05/16/2013 | US20130123433 Method for preparing poly(allylamine) hydrochloride and derivatives therefrom |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130122076 Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/16/2013 | CA2855372A1 Acc inhibitors and uses thereof |
| 05/16/2013 | CA2853872A1 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them |
| 05/16/2013 | CA2853784A1 Treatment of blood lipid abnormalities and other conditions |
| 05/16/2013 | CA2852991A1 Modulators of atp-binding cassette transporters |
| 05/16/2013 | CA2850458A1 [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 05/16/2013 | CA2846568A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists |
| 05/15/2013 | EP2592076A1 Substituted pyridine compound |
| 05/15/2013 | EP2591790A1 T cell apoptosis inducer |
| 05/15/2013 | EP2590997A2 Stabilized insulinotropic peptides and methods of use |
| 05/15/2013 | EP2590931A1 (2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals |
| 05/15/2013 | EP2590715A2 Use of deuterium depleted water for the treatment of insulin resistance |
| 05/15/2013 | EP2590665A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 05/15/2013 | EP2590658A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 05/15/2013 | EP2590650A2 Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound |
| 05/15/2013 | EP2590646A1 Method for inhibition of nf-kb gene expression |
| 05/15/2013 | EP2590643A2 Multi-component pharmaceuticals for treating diabetes |
| 05/15/2013 | EP2590634A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 05/15/2013 | EP2590520A2 Array of age-tailored nutritional formula with optimum fat content |
| 05/15/2013 | CN202933387U Disposable body surface pulse electrical stimulation plaster |
| 05/15/2013 | CN103108882A Polycrystalline type object of CDDO BIEA and use thereof |
| 05/15/2013 | CN103108863A Production of atorvastatin low in ether impurities |
| 05/15/2013 | CN103108649A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/15/2013 | CN103108644A Fat oxidation or energy metabolism enhancer |
| 05/15/2013 | CN103108634A Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases |
| 05/15/2013 | CN103108556A Ingredients derived from sphaeranthus indicus |
| 05/15/2013 | CN103103192A RNA (Ribonucleic Acid) interference fragment of targeted vascular angiotensin peptide and expression vector, hybrid clone cell strain and application thereof |
| 05/15/2013 | CN103103092A Silkworm male moth mulberry wine as well as preparation method thereof |
| 05/15/2013 | CN103103090A Silkworm chrysalis cordyceps wine and preparation method thereof |
| 05/15/2013 | CN103103089A Silkworm chrysalis cordyceps bombyx wine and manufacturing method thereof |
| 05/15/2013 | CN103103074A Healthful wine |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102314A Benzothiazole, benzimidazole, benzoxazole derivatives and preparation method and application thereof |
| 05/15/2013 | CN103102303A Benzylamine derivatives as CETP inhibitors |
| 05/15/2013 | CN103100089A Oral pH responsive intestinal targeting vector as well as preparation method and applications thereof |
| 05/15/2013 | CN103100029A Wu houshan bitter tea |
| 05/15/2013 | CN103099998A Traditional Chinese medicine decoction for treating diabetic nephropathy |
| 05/15/2013 | CN103099941A Traditional Chinese medicine oral liquid and preparation method thereof |
| 05/15/2013 | CN103099935A Traditional Chinese medicine composition for adjusting and controlling low-density lipoprotein level |
| 05/15/2013 | CN103099898A Formula Chinese herbal medicament capable of radically curing diabetes mellitus |
| 05/15/2013 | CN103099896A Herb tea for treating cardiovascular and cerebrovascular diseases |
| 05/15/2013 | CN103099890A Formula of traditional Chinese medicine moxibustion |
| 05/15/2013 | CN103099887A Granule with hypoglycemic effect for diabetics |
| 05/15/2013 | CN103099873A Green coffee bean extract sustained-release tablet and preparation method thereof |
| 05/15/2013 | CN103099865A Traditional Chinese medicine composition and preparation method and application thereof |
| 05/15/2013 | CN103099849A Medicinal composition for treatment of diabetes, preparation method and new application thereof |
| 05/15/2013 | CN103099847A Formula of traditional Chinese medicine for treating neurasthenia |
| 05/15/2013 | CN103099845A Method for extracting perillaseed hydrophilic chemical component from perillaseed oil residue |
| 05/15/2013 | CN103099836A Process for preparing lipid-diluting soft capsules |
| 05/15/2013 | CN103099832A Method for biotransformation of pseudo-ginseng by using Candida |
| 05/15/2013 | CN103099830A Processing method of vinegar-baked bupleurum root and applications thereof |
| 05/15/2013 | CN103099827A Extraction preparation method for flavones from grass leaves with blood enriching |
| 05/15/2013 | CN103099818A High energy active calcium capsule and preparation method thereof |
| 05/15/2013 | CN103099813A Preparation method and applications of deoxymononucleotide natrium-containing drug composition and preparation thereof |
| 05/15/2013 | CN103099807A Compound zinc gluconate and ibuprofen oral-administration composition for covering bitter taste and improving ibuprofen dissolution |
| 05/15/2013 | CN103099798A Preparation method of soybean isoflavone-chitosan slow-release microcapsules |
| 05/15/2013 | CN103099797A Propylene glycol mannate sulfate capsule and its preparation method |
| 05/15/2013 | CN103099796A Propylene glycol marinate sulfate-containing sustained-release preparation and preparation method thereof |
| 05/15/2013 | CN103099794A Vitamin C clathrate dispersible tablet |
| 05/15/2013 | CN103099789A Preparation method of vitamin C granules |
| 05/15/2013 | CN103099787A Vitamin C dry suspension |
| 05/15/2013 | CN103099210A Polygonum multiflorum nutrient tablet and making method thereof |
| 05/15/2013 | CN103099105A Porridge with diabetes mellitus treating effect and preparation method of porridge |
| 05/15/2013 | CN102743370B Novel use of diacerein |
| 05/15/2013 | CN102488741B Preparation method of pueraria root flavone extract and its product |
| 05/15/2013 | CN102443528B Wolfberry yam wine and preparation method thereof |
| 05/15/2013 | CN102309727B Chinese patent medicine for facial beautification and longevity |
| 05/15/2013 | CN102309475B Levocarnitine for injection and preparation method thereof |
| 05/15/2013 | CN102160889B Extract, composition, and use of overground part of hedychium coronarium koenig |
| 05/15/2013 | CN102076671B Triazole derivative or salt thereof |
| 05/15/2013 | CN102060921B High-stability VPAC2 type receptor specific activator MHDBAY, preparation method and application thereof |
| 05/15/2013 | CN101918423B Dipeptidyl peptidase-IV inhibitor |